Annual CFF
$7.86 M
+$7.86 M+100.00%
December 31, 2023
Summary
- As of February 6, 2025, CRVS annual cash flow from financing activities is $7.86 million, with the most recent change of +$7.86 million (+100.00%) on December 31, 2023.
- During the last 3 years, CRVS annual CFF has risen by +$6.54 million (+499.62%).
- CRVS annual CFF is now -91.73% below its all-time high of $94.95 million, reached on December 31, 2015.
Performance
CRVS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$50.00 K
-$30.32 M-99.84%
September 30, 2024
Summary
- As of February 6, 2025, CRVS quarterly cash flow from financing activities is $50.00 thousand, with the most recent change of -$30.32 million (-99.84%) on September 30, 2024.
- Over the past year, CRVS quarterly CFF has dropped by -$285.00 thousand (-85.07%).
- CRVS quarterly CFF is now -99.93% below its all-time high of $74.91 million, reached on September 30, 2015.
Performance
CRVS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$30.42 M
-$285.00 K-0.93%
September 30, 2024
Summary
- As of February 6, 2025, CRVS TTM cash flow from financing activities is $30.42 million, with the most recent change of -$285.00 thousand (-0.93%) on September 30, 2024.
- Over the past year, CRVS TTM CFF has increased by +$22.57 million (+287.27%).
- CRVS TTM CFF is now -80.41% below its all-time high of $155.25 million, reached on March 31, 2016.
Performance
CRVS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CRVS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | -85.1% | +287.3% |
| 3 y3 years | +499.6% | +100.0% | +100.0% |
| 5 y5 years | -88.0% | +100.0% | +100.0% |
CRVS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.4% | -100.0% | -99.8% | -100.0% | -51.1% | -100.0% |
| 5 y | 5-year | -87.4% | -100.0% | -99.8% | -100.0% | -52.0% | -100.0% |
| alltime | all time | -91.7% | -100.0% | -99.9% | +106.9% | -80.4% | -100.0% |
Corvus Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $50.00 K(-99.8%) | $30.42 M(-0.9%) |
| Jun 2024 | - | $30.37 M(>+9900.0%) | $30.70 M(+291.1%) |
| Mar 2024 | - | $0.00(0.0%) | $7.85 M(-0.1%) |
| Dec 2023 | $7.86 M(>+9900.0%) | $0.00(-100.0%) | $7.86 M(0.0%) |
| Sep 2023 | - | $335.00 K(-95.5%) | $7.86 M(+4.5%) |
| Jun 2023 | - | $7.52 M(>+9900.0%) | $7.52 M(>+9900.0%) |
| Mar 2023 | - | $4000.00(>+9900.0%) | $4000.00(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2022 | - | $0.00(0.0%) | $18.00 K(-99.9%) |
| Jun 2022 | - | $0.00(0.0%) | $18.35 M(-37.9%) |
| Mar 2022 | - | $0.00(-100.0%) | $29.57 M(-52.4%) |
| Dec 2021 | $62.16 M(+4644.9%) | $18.00 K(-99.9%) | $62.16 M(-1.9%) |
| Sep 2021 | - | $18.33 M(+63.5%) | $63.36 M(+40.5%) |
| Jun 2021 | - | $11.22 M(-65.6%) | $45.09 M(+33.0%) |
| Mar 2021 | - | $32.59 M(+2564.8%) | $33.90 M(+2487.8%) |
| Dec 2020 | $1.31 M(+5358.3%) | $1.22 M(+1810.9%) | $1.31 M(+1371.9%) |
| Sep 2020 | - | $64.00 K(+178.3%) | $89.00 K(+117.1%) |
| Jun 2020 | - | $23.00 K(>+9900.0%) | $41.00 K(+78.3%) |
| Mar 2020 | - | $0.00(-100.0%) | $23.00 K(-4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $24.00 K(-100.0%) | $2000.00(-87.5%) | $24.00 K(-87.6%) |
| Sep 2019 | - | $16.00 K(+220.0%) | $194.00 K(-43.6%) |
| Jun 2019 | - | $5000.00(+400.0%) | $344.00 K(-11.1%) |
| Mar 2019 | - | $1000.00(-99.4%) | $387.00 K(-99.4%) |
| Dec 2018 | $65.27 M(+4426.4%) | $172.00 K(+3.6%) | $65.27 M(-1.7%) |
| Sep 2018 | - | $166.00 K(+245.8%) | $66.41 M(+0.1%) |
| Jun 2018 | - | $48.00 K(-99.9%) | $66.37 M(+0.1%) |
| Mar 2018 | - | $64.88 M(+4860.6%) | $66.32 M(+4499.0%) |
| Dec 2017 | $1.44 M(-98.0%) | $1.31 M(+938.1%) | $1.44 M(+952.6%) |
| Sep 2017 | - | $126.00 K(>+9900.0%) | $137.00 K(+1145.5%) |
| Jun 2017 | - | $0.00(-100.0%) | $11.00 K(-99.8%) |
| Mar 2017 | - | $8000.00(+166.7%) | $7.02 M(-90.2%) |
| Dec 2016 | $71.36 M(-24.8%) | $3000.00(>+9900.0%) | $71.36 M(+1.0%) |
| Sep 2016 | - | $0.00(-100.0%) | $70.63 M(-51.5%) |
| Jun 2016 | - | $7.01 M(-89.1%) | $145.53 M(-6.3%) |
| Mar 2016 | - | $64.34 M(-8926.2%) | $155.25 M(+63.5%) |
| Dec 2015 | $94.95 M | -$729.00 K(-101.0%) | $94.95 M(-0.8%) |
| Sep 2015 | - | $74.91 M(+347.6%) | $95.68 M(+360.6%) |
| Jun 2015 | - | $16.73 M(+314.5%) | $20.77 M(+414.5%) |
| Mar 2015 | - | $4.04 M | $4.04 M |
FAQ
- What is Corvus Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual CFF year-on-year change?
- What is Corvus Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly CFF year-on-year change?
- What is Corvus Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals TTM CFF year-on-year change?
What is Corvus Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of CRVS is $7.86 M
What is the all time high annual CFF for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual cash flow from financing activities is $94.95 M
What is Corvus Pharmaceuticals annual CFF year-on-year change?
Over the past year, CRVS annual cash flow from financing activities has changed by +$7.86 M (+100.00%)
What is Corvus Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of CRVS is $50.00 K
What is the all time high quarterly CFF for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly cash flow from financing activities is $74.91 M
What is Corvus Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, CRVS quarterly cash flow from financing activities has changed by -$285.00 K (-85.07%)
What is Corvus Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of CRVS is $30.42 M
What is the all time high TTM CFF for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high TTM cash flow from financing activities is $155.25 M
What is Corvus Pharmaceuticals TTM CFF year-on-year change?
Over the past year, CRVS TTM cash flow from financing activities has changed by +$22.57 M (+287.27%)